Understanding and Improving Quality of Life Through a Wireless Activity Tracker: Observational Phase

NCT02674945 | Terminated

• 2 other identifiers: 1406M51644#2014NTLS054
• Study Type: observational
• Target: 29
• Locations: 1 country
• Sites: 1

Brief Summary

This project attempts to correlate wireless activity data with quality of life and sleep surveys in order to find a new method of monitoring patients during their treatment.

Conditions

Brain Tumor

Keywords

fitbit; activity tracker; sleep; quality of life

Outcome Measures

Primary Outcomes (1)

• Activity measured in steps

  1 year delineated by minute

Secondary Outcomes (3)

• Sleep

  per night over 1 year

• Quality of Life - SF-36

  months 0, 3, 6, 9, and 12

• Quality of Life - Fact- Br

  months 0, 3, 6, 9, and 12

Study Arms (1)

Wireless Activity tracker: Fitbit

Patients with brain tumor(s) will be give a wireless activity tracker (fitbit flex) to use during treatment. They will complete quality of life surveys and a sleep survey.

Device: Wireless Activity tracker: Fitbit

Interventions

Wireless Activity tracker: Fitbit DEVICE

Patients will wear a Fitbit flex

Wireless Activity tracker: Fitbit

Eligibility Criteria

• Age: 18 Years - 99 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Consentable patients suffering from a single or multiple primary or metastatic brain tumors

You may qualify if:

• diagnosed with primary or metastatic brain tumor
• able to wear wireless activity tracker
• able to complete QOL and sleep surveys every 3 months

You may not qualify if:

• unable to provide consent
• age \< 18
• lack of use of the wireless activity tracker for more than 2 consecutive months

Sponsors & Collaborators

• University of Minnesota: lead

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55455, United States

Location

MeSH Terms

Conditions

Brain Neoplasms

Condition Hierarchy (Ancestors)

Central Nervous System Neoplasms; Nervous System Neoplasms; Neoplasms by Site; Neoplasms; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases

Study Officials

• David Darrow, MD MPH

  University of Minnesota

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 4, 2016
• First Posted: February 5, 2016
• Study Start: September 1, 2014
• Primary Completion: September 1, 2018
• Study Completion: September 1, 2018
• Last Updated: June 28, 2022

Record last verified: 2022-06

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)